SOTIO Presents Interim Data from its Phase 1/1b Study of SO-C101 in Patients with Advanced Solid Tumors at SITC 2020

    NEXT STORY
    Seasonal Probiotics Company Jetson Adds Leading Pediatrician and OBGYN to Advisory “Gut Council”
    PREV STORY
    Bellerophon to Present at the H.C. Wainwright 6th Annual Israel Conference
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Friends of Prentice Raises More than $750,000 at Gala Benefiting Women’s Healthcare

    author_avatar
    NASDAQ Market News

    Precision Therapeutics Reports First Quarter 2018 Financial Results

    MINNEAPOLIS, May 15, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ:AIPT) (“Precision” or “the ...

    author_avatar
    NASDAQ Market News

    Synairgen announces positive results from trial of SNG001 in hospitalised COVID-19 patients

    author_avatar
    NASDAQ Market News